Manuscript Writing and Publication Support

A 100+ year-old global pharmaceutical company contacted Bioviser to seek assistance with manuscript writing in the infectious disease area. In this specific case, the within-family transmission of influenza virus from the first-infected patient in the family and treated with the study drug or a different antiviral drug was compared using a health insurance claims database. […]
Oral Presentation of Late-breaking Abstracts

A giant pharmaceutical company consulted Bioviser for the purpose of presenting the late-breaking results of a phase 2, multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy and safety of a monoclonal antibody in atopic dermatitis at two major dermatology conferences (one in Europe and another in the US). APPROACH In view of the late-breaking […]
Publication Planning for a global pharmaceutical company

Publication planning can be a long-drawn process involving many steps along the way. A large global specialty pharmaceutical company sought Bioviser’s assistance as a strategic partner for a publication planning project. They needed an in-depth literature review, publication analysis, and strategic/tactical planning for a rare chronic connective tissue disease affecting multiple systems, with focus on […]